Search

Author/Creator Gervais, Radj

21. TG4010 immunotherapy plus chemotherapy as first-line treatment of advanced non small cell lung cancer (NSCLC): Phase IIb results of the TIME trial. Issue 2 (December 2015)

Authors:
Nemunaitis, John; Papai, Zsolt; Léna, Hervé; Losonczy, Gyorgy; Forget, Frederic; Chouaid, Christos; Szczesna, Alexandra; Gervais, Radj; Ottensmeier, Christian; Beck, Joseph; Kazarnowicz, Andrzej; Westeel, Virginie; Debieuvre, Didier; Madroszyk, Anne; Felip, Enriqueta; Limacher, Jean; Quoix, Elisa...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 2(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

22. Treatment strategies for unresectable locally advanced non-small cell lung cancer in the real-life ESME cohort. (December 2021)

Authors:
Girard, Nicolas; Perol, Maurice; Simon, Gaëtane; Audigier Valette, Clarisse; Gervais, Radj; Debieuvre, Didier; Schott, Roland; Quantin, Xavier; Coudert, Bruno; Lena, Hervé; Carton, Matthieu; Robain, Mathieu; Filleron, Thomas; Chouaid, Christos
Journal:
Lung cancer
Issue:
Volume 162(2021)
Page Start:
119
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

23. Utility of serum anti‐cetuximab immunoglobulin E levels to identify patients at a high risk of severe hypersensitivity reaction to cetuximab. (24th October 2016)

Authors:
Dupont, Benoît; Mariotte, Delphine; Dugué, Audrey E.; Clarisse, Bénédicte; Grellard, Jean‐Michel; Babin, Emmanuel; Chauffert, Bruno; Dakpé, Stéphanie; Moldovan, Cristian; Bouhier‐Leporrier, Karine; Reimund, Jean‐Marie; Di Fiore, Frederic; Zanetta, Sylvie; Mailliez, Audrey; Do, Pascal; Peytier, An...
Journal:
British journal of clinical pharmacology
Issue:
Volume 83:Number 3(2017:Mar.)
Page Start:
623
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗